135 related articles for article (PubMed ID: 26671705)
1. Healthcare service utilisation costs attributable to rheumatoid arthritis in France: Analysis of a representative national claims database.
Fautrel B; Cukierman G; Joubert JM; Laurendeau C; Gourmelen J; Fagnani F
Joint Bone Spine; 2016 Jan; 83(1):53-6. PubMed ID: 26671705
[TBL] [Abstract][Full Text] [Related]
2. Burden of severe spondyloarthritis in France: A nationwide assessment of prevalence, associated comorbidities and cost.
Claudepierre P; Fagnani F; Cukierman G; de Chalus T; Joubert JM; Laurendeau C; Gourmelen J; Breban M
Joint Bone Spine; 2019 Jan; 86(1):69-75. PubMed ID: 29709699
[TBL] [Abstract][Full Text] [Related]
3. Costs of rheumatoid arthritis in Germany: a micro-costing approach based on healthcare payer's data sources.
Ruof J; Hülsemann JL; Mittendorf T; Handelmann S; von der Schulenburg JM; Zeidler H; Merkesdal S
Ann Rheum Dis; 2003 Jun; 62(6):544-9. PubMed ID: 12759292
[TBL] [Abstract][Full Text] [Related]
4. Migraine burden and costs in France: a nationwide claims database analysis of triptan users.
Donnet A; Emery C; Aly S; Allaf B; Cayre F; Mahieu N; Gourmelen J; Levy P; Fagnani F
J Med Econ; 2019 Jul; 22(7):616-624. PubMed ID: 30836035
[No Abstract] [Full Text] [Related]
5. Direct medical costs associated with rheumatoid arthritis in Turkey: analysis from National Claims Database.
Baser O; Burkan A; Baser E; Koselerli R; Ertugay E; Altinbas A
Rheumatol Int; 2013 Oct; 33(10):2577-84. PubMed ID: 23708559
[TBL] [Abstract][Full Text] [Related]
6. Healthcare service utilisation costs are reduced when rheumatoid arthritis patients achieve sustained remission.
Barnabe C; Thanh NX; Ohinmaa A; Homik J; Barr SG; Martin L; Maksymowych WP
Ann Rheum Dis; 2013 Oct; 72(10):1664-8. PubMed ID: 23117244
[TBL] [Abstract][Full Text] [Related]
7. The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology.
Bezin J; Duong M; Lassalle R; Droz C; Pariente A; Blin P; Moore N
Pharmacoepidemiol Drug Saf; 2017 Aug; 26(8):954-962. PubMed ID: 28544284
[TBL] [Abstract][Full Text] [Related]
8. Shifting Cost-drivers of Health Care Expenditures in Inflammatory Bowel Disease.
Click B; Lopez R; Arrigain S; Schold J; Regueiro M; Rizk M
Inflamm Bowel Dis; 2020 Jul; 26(8):1268-1275. PubMed ID: 31671186
[TBL] [Abstract][Full Text] [Related]
9. Direct medical expenditure associated with rheumatoid arthritis in a nationally representative sample from the medical expenditure panel survey.
Kawatkar AA; Jacobsen SJ; Levy GD; Medhekar SS; Venkatasubramaniam KV; Herrinton LJ
Arthritis Care Res (Hoboken); 2012 Nov; 64(11):1649-56. PubMed ID: 22674912
[TBL] [Abstract][Full Text] [Related]
10. Medical costs for Korean patients with rheumatoid arthritis based on the national claims database.
Kwon JM; Cho SK; Kim JH; Lee EK
Rheumatol Int; 2012 Sep; 32(9):2893-9. PubMed ID: 21898062
[TBL] [Abstract][Full Text] [Related]
11. Comorbidities in people living with HIV: An epidemiologic and economic analysis using a claims database in France.
Pourcher V; Gourmelen J; Bureau I; Bouee S
PLoS One; 2020; 15(12):e0243529. PubMed ID: 33332394
[TBL] [Abstract][Full Text] [Related]
12. Impact of bariatric surgery on the medical management and costs of obese patients in France: an analysis of a national representative claims database.
Czernichow S; Moszkowicz D; Szwarcensztein K; Emery C; Lafuma A; Gourmelen J; Fagnani F
Obes Surg; 2015 Jun; 25(6):986-96. PubMed ID: 25366293
[TBL] [Abstract][Full Text] [Related]
13. Comparison of outpatient reimbursement for interstitial cystitis/bladder pain syndrome and rheumatoid arthritis treatment in Taiwan: A nationwide population-based study.
Lin HY; Lee MH; Chang KM; Wu HC
Low Urin Tract Symptoms; 2019 Apr; 11(2):O162-O167. PubMed ID: 30073771
[TBL] [Abstract][Full Text] [Related]
14. Economic burden of coronary artery disease or peripheral artery disease in patients at high risk of ischemic events in the French setting: a claims database analysis.
Emery C; Torreton E; Briere JB; Evers T; Fagnani F
J Med Econ; 2020 May; 23(5):513-520. PubMed ID: 31928390
[No Abstract] [Full Text] [Related]
15. Prevalence and economic burden of cardiovascular diseases in France in 2013 according to the national health insurance scheme database.
Tuppin P; Rivière S; Rigault A; Tala S; Drouin J; Pestel L; Denis P; Gastaldi-Ménager C; Gissot C; Juillière Y; Fagot-Campagna A
Arch Cardiovasc Dis; 2016; 109(6-7):399-411. PubMed ID: 27079468
[TBL] [Abstract][Full Text] [Related]
16. Impact of medical practices on the costs of management of rheumatoid arthritis by anti-TNFalpha biological therapy in France.
Fautrel B; Woronoff-Lemsi MC; Ethgen M; Fein E; Monnet P; Sibilia J; Wendling D
Joint Bone Spine; 2005 Dec; 72(6):550-6. PubMed ID: 15996504
[TBL] [Abstract][Full Text] [Related]
17. Hidden cost of rheumatoid arthritis (RA): estimating cost of comorbid cardiovascular disease and depression among patients with RA.
Joyce AT; Smith P; Khandker R; Melin JM; Singh A
J Rheumatol; 2009 Apr; 36(4):743-52. PubMed ID: 19228658
[TBL] [Abstract][Full Text] [Related]
18. Is rheumatoid arthritis care more costly when provided by rheumatologists compared with generalists?
Gabriel SE; Wagner JL; Zinsmeister AR; Scott CG; Luthra HS
Arthritis Rheum; 2001 Jul; 44(7):1504-14. PubMed ID: 11465700
[TBL] [Abstract][Full Text] [Related]
19. Economic burden of highly active relapsing-remitting multiple sclerosis patients in the French national health insurance database.
Vandhuick O; Payet M; Préaud E; Lortet-Tieulent J; Raguideau F; Chevreuil O; van Hille B; Kwiatkowski A
Expert Rev Pharmacoecon Outcomes Res; 2021 Oct; 21(5):1135-1144. PubMed ID: 34165377
[TBL] [Abstract][Full Text] [Related]
20. Nationwide population-based epidemiologic study of rheumatoid arthritis in Taiwan.
Lai CH; Lai MS; Lai KL; Chen HH; Chiu YM
Clin Exp Rheumatol; 2012; 30(3):358-63. PubMed ID: 22513120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
